Platform

One platform. Staged commercialization.

Platform products and services first, LiverCube decision packages for pharma next, and patient-matched hearts long term. Same platform and workflow, multiple value drivers.

LAYER 1 · NOW

Platform Products & Services

Built systems, service and support, consumables, and application-specific platform work. Layer 1 commercialization is already real through external deployment and first platform revenue.

MAK007-4XConsumablesSupport
LAYER 2 · NEAR-TERM

LiverCube Decision Packages

Perfused liver tissue models for drug safety and translational decisions. Customers buy a decision package, not a cube: study scope, tissue workflow, measurements, QC and interpretation.

PharmaDILIDecision packages
LAYER 3 · LONG-TERM

Patient-matched Hearts

Same platform and workflow, multiple value drivers. The workflow that supports pharma decision packages today compounds toward patient-matched hearts as the long-term North Star.

Long-termTherapeuticsHeart roadmap
Platform

Hardware. Software. Biology.
Built end-to-end.

Built around a patent-pending multi-material printhead and an integrated workflow for perfusion, maturation, QC and traceability. The stack is designed to print, perfuse, mature, measure, QC and trace living tissues as one controlled workflow.

Bioprinting

Patent-pending multi-material printhead with nozzle-to-nozzle switching in under one second. Modular architecture configurable from 4 to 32 separate extruders.

Perfusion

Controlled flushing and perfusion workflows that turn printed channels into perfusable tissue architectures, with QC gates and traceable process data.

Bioinks & Biomaterials

Cell-compatible bioinks and support materials designed for complex geometry, perfusion workflows and tissue-specific tuning.

Vascularization Algorithm

Computational geometry for vascular layouts that support perfusion and diffusion-aware tissue design.

AI Autonomy

Software and data capture for repeatability, QC, traceability and future AI-guided operation.